Here you can access to information about organisations operating in the Health sector in the cross-border cooperation region of Galicia (Spain) - Norte (Portugal), and find/announce opportunities to establish new scientific, technological, clinical or commercial partnerships with these organisations. You’re free to access all the information available so far. If you want to announce an opportunity, and you're not registered yet, please register here.

[HIPOD's starting date: 18 January 2019]

Organisations
Opportunities: Offer
Opportunities: Demand
News & Events
Results
News & Events
Events
The JoinHealth webinars are back!Join us every Tuesday from October 12th to hear and discuss about:-IP protection-IP protection in Health software-European Health data Space (EHDS)-Remote Clinical Trials-Portugal as a Living lab for Medtech (live from MEDICA)-(...)The webinars are free and open to the community, but registration is mandatory.Registrations here!
Organisations
Other | Biotech Company
This is an invention that encapsulate proteins. The advantages are: 1. Stabilization of biological molecules that remain functional for at least 20 cycles of reaction => encapsulation process RESPECT the configuration of antibodies, antigens, enzymes. 2. Capacity of carrying different biological molecules in an independent format; e.g. besides mono-enzymatic this composite can work as a catalytic-cascade support: different enzymes can be encapsulated separately and at the same time. 3. Encapsulated proteins gain denaturation-resistance and the robustness of the composite enable its intensive use in: ►Medical Diagnosis Devices - encapsulated antibodies or antigens, in which the composite is permeated by a liquid biological sample and the counterparts’ antigens (or antibodies) or biomarkers from the donner patient are detected. ►Biocatalysis - encapsulated enzymes are advantageous over soluble enzymes => no need for continuous replacement of the enzymes, easier separation from the products, higher stability under industrial harsh conditions. This is a profitably invention because: a)- Point-of-Care Test (POCT) market in 2011 was in the order of USD 15 billion. The registration was in 2017 of 23 billion USD and a market growth rate around 10% per annum. Projection of the global POCTs market for 2022: USD 38 billion. b)- Biocatalysis use enzymes for manufacturing products of high commercial value in fine chemicals, pharmaceuticals and agrochemical intermediates, besides traditional applications in food industry. Enzymes are widely relevant in industrial budgets. This invention is under international patent: the novelty, inventive step and industrial application of all claims were fully recognized before IP international registration request, and that complied not only the method to synthetize both composites but the final product as well. COROLARIUM: we intend to market this invention.
Organisations
Other | Biotech Company
This is an invention that encapsulate proteins. The advantages are: 1. Stabilization of biological molecules that remain functional for at least 20 cycles of reaction => encapsulation process RESPECT the configuration of antibodies, antigens, enzymes. 2. Capacity of carrying different biological molecules in an independent format; e.g. besides mono-enzymatic this composite can work as a catalytic-cascade support: different enzymes can be encapsulated separately and at the same time. 3. Encapsulated proteins gain denaturation-resistance and the robustness of the composite enable its intensive use in: ►Medical Diagnosis Devices - encapsulated antibodies or antigens, in which the composite is permeated by a liquid biological sample and the counterparts’ antigens (or antibodies) or biomarkers from the donner patient are detected. ►Biocatalysis - encapsulated enzymes are advantageous over soluble enzymes => no need for continuous replacement of the enzymes, easier separation from the products, higher stability under industrial harsh conditions. This is a profitably invention because: a)- Point-of-Care Test (POCT) market in 2011 was in the order of USD 15 billion. The registration was in 2017 of 23 billion USD and a market growth rate around 10% per annum. Projection of the global POCTs market for 2022: USD 38 billion. b)- Biocatalysis use enzymes for manufacturing products of high commercial value in fine chemicals, pharmaceuticals and agrochemical intermediates, besides traditional applications in food industry. Enzymes are widely relevant in industrial budgets. This invention that is under international patent: the novelty, inventive step and industrial application of all claims were fully recognized before IP international registration request, and that complied not only the method to synthetize both composites but the final product as well. COROLARIUM: we intend to market this invention.
Organisations
Other | Healthcare Provider
The HPA Health Group provides medical support throughout the Algarve, Alentejo and Madeira island and operating since 1996. It is a reference in private health care in the Algarve region. In addition to the healthcare units, the HPA Health Group includes other companies such as ambulance services, parapharmacies, clinical analysis laboratories, imaging and cardiovascular intervention centers. It consists of six hospital units: Hospital Particular do Algarve - Alvor 24H, Hospital Particular do Algarve - Gambelas - Faro 24H; Hospital de São Camilo – Portimão; Hospital São Gonçalo de Lagos - Lagos, Hospital Particular do Alentejo - Sines and Hospital Particular da Madeira - Funchal 24H and Clinics in various parts of the Algarve, Alentejo and Madeira island.
Organisations
Norte (Portugal) | Other
MyCareforce is a 100% digital platform that has a pool of +1400 nurses interested in being connected with available shifts in Healthcare Institutions.
News & Events
News
Today was the Results Presentation Session* of the project CovidLearning - Knowledge sharing for health professionals. CovidLearning is a collaborative project combining AI-based solutions that allow accessing the latest scientific evidence and information related to SARS-CoV-2 and COVID-19, in order to improve the quality of information for health professionals, researchers and to the community. At search.covid-learning.com you will have access to a qualitative analysis of scientific articles, produced by machine-learning algorithms and based on widely accepted criteria.If you want to know more about the project go to www.covid-learning.com.Partners:iCognitus4ALL - IT SolutionsCentro de Medicina Digital P5ICVS - Life and Health Sciences Research InstituteCINTESIS - Center for Health Technology and Services Research/Faculdade de Medicina da Universidade do PortoHealth Cluster PortugalThis project (No. 65157/NORTE-01-02B7-FEDER-065157) was financed by NORTE 2020, through the European Structural and Investment Funds, within the scope of SI I&D Empresas - COVID-19.*The recording of the session will be soon available on the Health Cluster Portugal YouTube channel: https://lnkd.in/dHrZGpu
Opportunity Demand
Generic demands for unmet needs | Other
IVD Portugal is a plastic injection molding company based in Coruche. Our Mission is to provide medical devices and products with the highest quality according to MD specification ISO 13485; Directive 93/42 & 98/79 and Regulation 745/2017 & 746/2017. Our customer focus are: B2B partnerships; Company consortium for new product developments; Laboratories and Hospitals.
News & Events
Events
Spring brings a new edition of JoinHealth organized by Health Cluster Portugal and EIT Health#JoinHealth Spring Welcome Webinars | May and June | Tuesdays at 2:30pmThis edition will cover topics such as interoperability of data in health, preclinical research, sales, cybersecurity and more...Stay tuned to the topics and dates at www.healthportugal.com.
Organisations
Other | Contract Manufacturing Organisation
IVD Portugal is a plastic injection moulding company based in Coruche. Our Mission is to provide medical devices and products with the highest quality according to MD specification ISO 13485; Directive 93/42 & 98/79 and Regulation 745/2017 & 746/2017. Our costumer focus are : - B2B partnerships; - Company consortium for new product developments; - Laboratories and Hospitals.